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ABSTRACT
Depigmentation in  vitiligo occurs as a result of progressive loss of functioning epidermal 
melanocytes, and currently various modalities have been developed to re-functioning these 
cells. However, in area with poor melanocytes reservoir, such as old-persistent lesions 
or lesions on bony prominence, the modalities are hardly to achieve repigmentation. 
Since spontaneous repigmentation of vitiliginous skins begin mostly in follicular areas, 
reactivation of melanocyte precursors along the outer root sheath of hair follicle is expected 
to have better on this pigmentation. Melanocyte precursor came from melanocyte stem 
cells that originally located on bulge area of hair follicles. The latest surgical intervention 
in vitiligo is transplantation of melanocyte stem cells. Clinical experiments indicated that 
the transplantation can be performed either by transplantation of extracted follicular units 
or single cell suspension harvested from this area. By single cell suspension treatment, 
a 50 cm2 of vitiliginous skin can be handled by 15 autologous hair follicular units. These 
procedures are easy and can be performed by any dermatologist especially who has been 
trained in dermatologic surgery as well as in cellular based therapies.
ABSTRAK
Depigmentasi pada vitiligo terjadi akibat kehilangan secara progesif fungsi melanosit 
epidermal dan saat ini berbagai modalitas telah dikembangkan untuk mengembalikan 
fungsi sel. Namun demikian, daerah dengan sumber melanosit yang rendah seperti lesi 
persisten yang lama atau lesi pada tonjolan tulang, modalitas tersebut sulit mengalami 
repigmentasi. Sejak repigmentasi spontan kulit vitiliginus mulai terutama di daerah folikel, 
reaktivasi pekusor melanosit sepanjang selubung akar luar folikel rambut diharapan proses 
pigmentasi berjalan lebih baik. Prekusor melanosit berasal dari sel punca melanosit yang 
terletak di area tonjolan folikel rambut. Intervensi bedah paling akir pada vitiligo adalah 
transplantasi sel punca melanosit. Pengalaman klinik menunjukkan bahwa transplantasi 
dapat dilakukan baik dengan transplantasi unit folikel yang diekstrak atau suspensi sel 
tunggal yang diambil dari area ini. Dengan pengobatan suspensi sel tunggal, 50 cm2 kulit 
vitiligo dapat dilakukan oleh 15 unit folikel rambut autolog. Prosedur ini mudah dan dapat 
dilakukan oleh dokter spesialis kulit dan kelamin yang telah dilatih dalam bedah kulit juga 
pengobatan berbasi sel. 
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INTRODUCTION
As, vitiligo is an acquired pigmentation 
disorder manifested with development of white 
macules or patches on affected skin due to a 
progressive loss of functioning of epidermal 
melanocytes. The basic mechanism has not 
yet been clearly identified, however, various 
mechanisms have been proposed, including 
genetic association,1,2 autoimmunity and 
oxidative stress,3-5 neurohormonal imbalance,6 
abnormalities in the microenvironment 
surrounding the melanocytes7-9 and intrinsic 
defects of melanocytes and periphery T cell 
regulator which promote innate immune 
attack.10,11
Various modalities have been developed 
to treat vitiliginous skins, among others : a) 
anti-oxidant agents such as: Polypodium 
leucotomos as adjunct therapy with PUVA,12 
or fish oil13; b) immunosuppressive agents such 
as: topical corticosteroid,14 tacrolismus,15-17 
or calcipotriol,18,19 either used as single 
modality or in combination with NB-UVB or 
excimer laser; c) UVA light combined with 
photosensitizer agent such as: psoralen,20,21; 
d) oral minocycline22,23 which nevertheless 
less effective than NB-UVB.24 Previous 
study showed that minocycline could protect 
melanocytes from H2O2-induced cell death.
25 
Systematic review revealed that NB-UVB 
showed equivalent therapeutic efficacies 
to UVA, PUVA or 308-nm Excimer Laser, 
in > 50% and > 75% of repigmentation.26 
However, these modalities have limitations, 
especially in achieving total repigmentation. 
In facts, failure of repigmentation is usually 
found among old-persistent lesions or lesions 
on skin over the bony prominences with poor 
melanocytes reservoir. Cui et al.,27 reported 
that spontaneous repigmentation of vitiligo 
usually begins as multiple dots of pigmentation 
around of hair follicle areas where they are 
rich with melanocytes reservoir. Since human 
epidermal melanocytes stem cells can be found 
along bulge area of hair follicles, and follicle 
unit extractions method has been developed 
by trichologists where part of the bulge area is 
also involved, transplantation of melanocyte 
stem cells is now become possible. Here, the 
basic technique of this modality, and method 
of transplantation is described. 
MELANOCYTE STEM CELLS
Characteristic of Melanocyte Stem Cells
Stem cells are defined as cells that able 
to self-renew so they can divide and maintain 
their population and provide specialized and 
differentiated daughter cells of their specific 
tissue type.28,29 In addition, the degree of 
plasticity and the markers expressed is different 
between adult and embryonic stem cells, as 
well as between adult stem cells of different 
tissue types. Stem cells are present in an 
environment as a special cellular organization 
called the niche.30,31 The signals within niche 
has important factor in regulation of stem 
cell’s self-renewing and differentiation.32,33
Melanocyte stem cells (MSCs) were first 
identified in the hair follicle and are located 
in the bulge region as their niche (FIGURE 
1).34 They differentiate into hair follicle 
melanocytes at the beginning of anagen phase 
and undergo apoptosis at catagen phase.35
MSCs are generated from melanoblasts 
that populate the hair follicle bulge,  and 
they are stimulated to become inactive by 
their niche at the final stage of hair follicle 
morphogenesis.36,37 The responsible niche 
for this purpose is signaling of transforming 
growth factor β (TGF-β) by inducing cell 
cycle arrest, down-regulation of MITF 
(Microphthalmia-Associated Transcription 
Factor) gene expression, and suppression 
of melanogenic genes in melanoblasts. 
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FIGURE 1.  Location of MSCs along hair follicle (left), and extracted 
hair follicle unit (right)
Signaling TGF-β through TGF-β RII is also 
as key role in regulation melanocyte stem 
cell immaturity and quiescence.38 Both states 
of immaturity and quiescent is important 
factor for maintenance MSCs population 
during growing phase of hair cycle. In this 
condition, Bcl2, an anti-apoptotic factor, is 
essential for survival of MSCs during this 
phase.37,38 MITF gene product, namely MITF, 
is also an important transcription factor to 
prevent premature MSCs differentiation and 
pigmentation.38 Hair graying, as one phenotype 
of human aging, occurs as a result of loss of 
hair follicle melanocytes which is caused by 
gradual loss of MSCs.37,39 Loss of MSCs is 
caused by failure of MSCs maintenance in the 
bulge region of hair follicles.37 Inappropriate 
maintenance of MSCs results in the failure of 
MSCs to proliferate and differentiate, migrate 
to wrong places, or death.39 All of these events 
are related to TGF- β signaling. Other studies 
indicated that TGF-β production and TGF-β 
RII expression is down-regulated among aged 
skin.40,41
Isolation and cultivation of MSCs
The best source of MSCs is hair follicles, 
especially the outer root sheats of hair 
follicles. These cells can be propagated to 
multiply by explant method,42 but the hair 
shaft must be plug out together with dermal 
papilla because dermal papilla is an important 
niche for epidermal stem cells, including 
MSCs.43,44 For this purpose, follicular unit 
extraction (FIGURE-1) either by using mini-
punch instrument or micro motorized mini 
punch is considered as the best method.45 
This technique allows the hair of donor sites 
to regrowth with the absence or minimal 
scarring. Furthermore, extracted follicular 
unit contains dermal papilla together with a 
part of bulge area.46 Cultivation of extracted 
follicular unit can be done by using stem cell-
medium.42 In the Dermatology Department 
Universitas Gadjah Mada, cellular expanding 
with melanin production can be obtained by 
Dulbecco’s minimal essential media (DMEM) 
supplemented with 10 % fetal bovine serum 
(FIGURE 2).
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A single cell suspension can be obtained 
from extracted hair follicles by simple trypsin 
digestion and cultured in melanocyte growth 
medium with stem cell factor. To maintenance 
their proliferation rates, a second passage 
of keratinocytes must be added into culture 
dish as feeder layer, after day 21.47 In this 
method, beside of MSCs, neural crest stem 
cells (NCSCs) can also be alternative as 
concomitant culture.48
MSCs in vitiligo
Controversy of totally loss or inactivation 
state of MSCs of vitiliginous lesion has 
existed for a long time. In order to get certain 
answer for this problem, Seleit et al.,49 
evaluated the MSCs-lineage in follicular and 
inter-follicular vitiliginous epidermis through 
immunohistochemical localization of Human 
Melanoma Black-45 (HMB-45) and Tyrosinase 
Related Protein 2 (TRP2). They found that 
MSCs were detected in 44% of inter-follicular 
epidermis and 46.7% of follicular epidermis 
of vitiliginous lesions. Melanocyte precursors 
were detected in 54% of inter-follicular 
and 63.3% of follicular in skin lesions. The 
existence of MSCs and melanocyte precursors 
was higher among black hair than white hair 
of vitiliginous lesions. This finding indicates 
that killing melanocytes by innate immune 
FIGURE 2. Culture expansion of melanin-producing cells from extracted hair follicles
attack is not directing against MSCs, but 
into mature melanocytes. This finding also 
supports previously hypothesis that failure 
of re-pigmentation of vitiliginous lesions is 
located in skin area with poor hair follicles.50
The presence MSCs on vitiliginous lesions 
may be caused by elevation of serum level of 
TGF-β, as it has been described on above. 
Serum level of TGF-β of non-segmental 
vitiligo is indeed elevated.51,52 Conversely, 
this elevation is responsible for failure 
residual melanocytes in producing melanin as 
it has been discovered by Kim et al.,53 When 
autologous MSCs from normal skin planned 
to elevate numbers of precursor melanocytes 
in vitiliginous lesions, those transplanted 
MSCs must receive special treatment so that 
inhibition of melanin production by TGF-β can 
be minimize. Blocking TGF-β RII expression 
can be achieved by giving ultraviolet 
irradiation onto vitiliginous lesions after 
MSCs transplantation.54,55 Study conducted 
among neonatal mouse skin indicated that 
repeated ultraviolet B (UVB) irradiation can 
induce MSCs differentiation into melanocytes 
and melanin production.56 Broad band UVB 
showed a better efficacy in awakening MSCs 
than narrow band UVB.57 Similar event 
also happened among hair follicles and the 
epidermis of human vitiliginous skins.58
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MELANOCYTES STEM CELLS 
TRANSPLANTATION ON 
VITILIGINOUS LESIONS
Principle of surgical interventions
The basic principle of surgical treatment in 
vitiligo is to achieve cosmetically acceptable 
repigmentation of the vitiliginous areas by 
transplantation of autologous melanocytes or 
MSCs from the unaffected pigmented skin to 
the vitiliginous skins. Surgical intervention 
cannot stop the progression of this disease, 
therefore this technique is only indicated for 
stable vitiligo that does not show adequate 
response to medical therapies.59 Although 
there is no universal consensus on how to 
define stable vitiligo, the Indian Association 
of Dermatology,  Venereology and 
Leprology (IADVL) establish  a consensus 
recommendations to define this stability 
that is a patient reporting no new lesions, no 
progression of existing lesions, and absence 
of Koebner phenomenon during the past one 
year.60
There are various methods of surgical 
intervention for vitiliginous skin, some of 
those techniques are attempted to transplant 
melanocytes from the donor to the recipient 
areas, such as: suction blister grafting, thin 
epidermal grafting, and mixed epidermal cell 
suspensions grafting,61 whereas others may 
provide melanocytes, melanocyte precursors, 
and also MSCs, such as: hair follicular 
grafting and mini-punch grafting. Among 
hair follicular grafting which is harvested 
by follicular unit extractions, the grafts are 
composed by hair shaft, a part of hair bulge 
where MSCs are located, and dermal papilla 
as niche of MSCs and other epidermal stem 
cells.
Hair Follicle Unit Extractions (FUE)
Before FUE was developed in hair 
transplantation surgery, follicular unit 
transplantation was obtained from hairy skin 
stripping followed by stereo-microscopic 
dissections. This strip-harvesting technique 
caused donor scarring on occipital area which 
sometimes are difficult to be covered by 
surrounding hair. FUE was firstly introduced 
by Rasmann et al.,62 who used one-millimeter 
punch to insulate follicular units from the 
surrounding tissues down to the level of the 
mid dermis then followed by extractions 
of these units with forceps. By this method, 
scarring due to single strip harvesting does 
not occur and microscopic dissections are not 
needed. In addition, by leaving a part of bulge 
area in punched holes, hair shaft can regrowth 
and hair density on donor area is not markedly 
disturbed46 (FIGURE 3). Furthermore, in 
order to increase survival rate of harvested 
grafts, Senthi et al.,63 modified FUE hair 
transplantation by implanting FUEs as soon 
as they were harvested and this technique 
showed a better results in hair transplantation.
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FIGURE 3. Follicular Unit Extraction Follicular unit extraction (red-circle) (left), leave a part 
of bulge area as a source for hair regrowth (right)
Aplication FUE onto Vitiliginous Skin
Direct application of autograft hair follicles 
onto vitiliginous skin has been reported by 
many authors. Recipient area must be non-
hairy areas otherwise hair removal treatment 
must be performed afterward. Transplantation 
of FUE onto the right eyebrow of eight years 
duration of 12 years old female was reported 
by Sacchidanand et al.,64 which procedure was 
easy, scarless and sutureless, but seemly only 
for small size of stable vitiligo. Aziz Jalani 
et al.,65 reported that occipital hair follicles 
transplantation, harvested by punch biopsy 
instrument then dissected to various follicular 
units can induce repigmentation of persistent 
segmental vitiligo among 10 patients. FUE 
can be harvested from hair body or scalp 
areas and FUE from this region indicate same 
characteristic with FUE from scalp area, such 
as reported by Chouhan et al.,66 when they 
successfully transplanted FUE from the right 
upper thigh to the left shin, calves and both 
ankles vitiliginous skin. Repigmentation rates 
of hair follicles transplantation is equal with 
those achieved by multiple mini punch grafts, 
however mini punch grafting is much easier 
and the procedure is faster than hair follicles 
transplantation method. Based on this finding, 
Mapar et al.,67 suggested to perform multiple 
mini punch grafts for stable vitiligo. In 
Department of Dermatology and Venereology 
Sardjito General Hospital, we performed 
multiple mini punch grafts from the left upper 
thigh skin with vellus hairs and transplanted 
onto the left eyebrow of 17 years old female 
of a Sardjito Hospital’s segmental vitiligo 
patient as additional procedure of suction 
blister grafting (FIGURE 4).
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FIGURE 4. Mini punches graft from vellus hairs area onto eyebrow area as additional procedure after suction 
blister grafting of a Sardjito Hospital’s patient (From left to right side: before procedure, a week 
after suction blister grafting, vellus hair mini punch grafts, a week later)
Except for hairy areas, another limitation 
of FUE transplantation is convenient only 
in small areas of skin. For larger areas, 
FUE transplantation must be modified to 
become hair follicle cell suspensions so that 
it can be sprayed onto large dermabraded 
vitiliginous skin, similar to mixed epidermal 
cell suspensions grafting method. The 
advantages of this technique are the amount 
of MSCs and melanocytes precursor collected 
in this suspension. Preparation of extracted 
hair follicle outer root sheath cell suspension 
can refer to the method of Kumar et al.68 By 
simple warm trypsin digestion of extracted 
hair follicle units, a large number of mixed 
cells can be obtained (FIGURE 5).
FIGURE 5.  Enzymatic digestion of bulge area (red-
circle) of extracted hair follicle units.
Enzymatic digestion by trypsin must be 
performed for at least 90 minute in 370C. In the 
next step, cell suspension collected from this 
procedure can be sprayed onto dermabraded 
vitiliginous skin after removing the residual 
trypsin. A number of 15 hair follicles can 
be used to cover 30.8 ± 26.5 cm2 and the 
repigmentation rates can be around 65.7 ± 
36.7%.68 Another advantage of this procedure 
is resistance of transferred melanocyte stem 
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cells from innate immune attack as one of 
basic mechanism of vitiligo.69
CONCLUSION
Loss of functioning epidermal melano-
cytes which cause depigmentation of vitiligi-
nous skin can be ameliorated by MSCs 
transplantation. Bulge area of hair follicle is 
a rich source of MSCs and transplantation 
of MSCs can be performed by FUE of hair 
transplantation especially on haired skin with 
limited affected areas. For larger area, spraying 
cell suspension of extracted follicular unit on 
to dermabraded area is believed to be the best 
choice. 
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